Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease
A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying Potential of Transdermal Nicotine in Early Parkinson's Disease in Germany and the USA A Randomized, Placebo-controlled, Double-blind, Multi-center Trial to Assess the Disease-modifying P ...
Parkinson's Disease
Drug: nicotine transdermal patch
James BOYD MD
Michael J. Fox Foundation for Parkinson's Research;Parkinson Study Group (PSG);International Parkinson Fonds (IPF);German Parkinson Study Group (GPS);German Parkinson Society (DPG);Philipps-University Marburg, Germany Michael J. Fox Foundation for Parkinson's Research;Parkinson Study Group (PSG);International Parkins ...
A study in U.S. and Germany to show if patients with an early stage of Parkinson's disease could be treated with a nicotine patch. In this study the nicotine patch is being compared to a placebo patch. The placebo patch is identical in appearance to the nicotine patch but does not contain any active ingredients. A study in U.S. and Germany to show if patients with an early stage of Parkinson's disease could be ...
A randomized, placebo-controlled, double-blind, multi-center trial to assess the disease-modifying potential of transdermal nicotine in early Parkinson's disease in Germany and the USA (NIC-PD) - NIC-PD A randomized, placebo-controlled, double-blind, multi-center trial to assess the disease-modifying p ...
Early PD subjects within 18 months of diagnosis and not expected to require dopamine agonist or levodopa therapy for 1 year, with Hoehn and Yahr stage <2, with stable (>2 months) MAO-B inhibitor therapy allowed MedDRA version: 16.1;Level: PT;Classification code 10061536;Term: Parkinson's disease;System Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10] Early PD subjects within 18 months of diagnosis and not expected to require dopamine agonist or levo ...
Trade Name: Nicotinell 17,5 mg/24-Stunden-Pflaster Product Name: Nicotinell Other descriptive name: NICOTINE Trade Name: Nicotinell 35 mg/24-Stunden-Pflaster Product Name: Nicotinell Other descriptive name: NICOTINE Trade Name: Nicotinell 17,5 mg/24-Stunden-Pflaster Product Name: Nicotinell Other descriptive name: NI ...
Efficacy of Transdermal Nicotine, on Motor Symptoms in Advanced Parkinson's Disease
Efficacy of Transdermal Nicotine, on Motor Symptoms in Advanced Parkinson's Disease(One Daily Administration).A Controlled Randomised Study, in Two Parallel Groups and Single Blind in 40 Patients. Efficacy of Transdermal Nicotine, on Motor Symptoms in Advanced Parkinson's Disease(One Daily Admini ...
Idiopathic Parkinson's Disease
Drug: Transdermal nicotine;Other: Usual drug treatment of Parkinson's disease